Progressive Cholestasis and Biliary Cirrhosis After Initiating Oral Semaglutide: Report From the Drug-Induced Liver Injury Network

Semaglutide has little hepatic metabolism and is deemed low risk for causing drug-induced liver injury (DILI). We present a case of DILI from the US DILI Network. The case involved a 51-year-old man with type 2 diabetes who presented with jaundice and acute-on-chronic kidney disease 6 months after s...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Jiayi, Mathur, Karan, Muldoon, Jessica L., Ghabril, Marwan, Chalasani, Naga, Vuppalanchi, Raj
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9794239/
https://www.ncbi.nlm.nih.gov/pubmed/36600793
http://dx.doi.org/10.14309/crj.0000000000000922

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9794239/
https://www.ncbi.nlm.nih.gov/pubmed/36600793
http://dx.doi.org/10.14309/crj.0000000000000922

Ejemplares similares